Related Experiment Video
Updated: Jan 6, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Therapeutic Plasma Exchange in Pediatric Care: Insights from a Tertiary Care Centre Experience
Sphurti Chowdhary1, Krishna Mohan Gulla1, Satya Prakash2
1Department of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Insights
Therapeutic plasma exchange (TPE) is safe and effective for pediatric renal and non-renal conditions, including hemolytic uremic syndrome and autoimmune encephalitis. However, outcomes are impacted by delayed presentation and limited transplant options.
Area of Science:
- Pediatric Nephrology
- Pediatric Neurology
- Pediatric Critical Care
Background:
- Therapeutic plasma exchange (TPE) is an extracorporeal procedure used for various pediatric conditions.
- Assessing TPE's safety, efficacy, and outcomes in children is crucial for optimizing treatment strategies.
- Tertiary care centers play a vital role in managing complex pediatric cases requiring advanced therapies like TPE.
Purpose of the Study:
- To evaluate the safety, efficacy, and clinical outcomes of therapeutic plasma exchange (TPE) in pediatric patients.
- To identify patient subgroups that benefit most from TPE and factors influencing outcomes.
- To analyze the spectrum of indications for TPE in a tertiary care setting.
Main Methods:
- Retrospective analysis of pediatric patients who underwent TPE between January 2020 and July 2024.
- Data collection from hospital records at a tertiary care hospital in Eastern India.
- Analysis of indications, TPE cycles, patient demographics, and outcomes.
Main Results:
- Forty children underwent 184 TPE cycles; common indications included liver disease (35%), renal diseases (27.5%), and secondary hemophagocytic lymphohistiocytosis (22.5%).
- Excellent outcomes were observed in autoimmune encephalitis and ASFA category I renal diseases.
- High mortality was linked to delayed presentation, organ failure, and lack of liver transplant facilities.
Conclusions:
- Therapeutic plasma exchange (TPE) demonstrates effectiveness in treating pediatric hemolytic uremic syndrome and anti-N-methyl-D-aspartate receptor encephalitis.
- TPE can be safely and effectively administered for both renal and non-renal indications in children.
- Optimizing TPE protocols and timely intervention are essential for improving pediatric patient outcomes.
Objective:
To assess the safety, efficacy and outcomes of therapeutic plasma exchange (TPE) in children at a tertiary care hospital.
Methods:
Data of children who underwent TPE between January 2020 and July 2024 at a tertiary care hospital in Eastern part of India, were collected from the hospital records and analyzed.
Results:
Forty children with mean (SD) age of 7.5 (3) years underwent 184 cycles of TPE during the study period. Liver disease was the commonest indication (n=14, 35%) followed by renal diseases (n=11, 27.5%) and secondary hemophagocytic lymphohistiocytosis (HLH, n=9, 22.5%). Out of 40 children,16 were discharged, 21 succumbed to the illness and 3 left against medical advice. Children with autoimmune encephalitis and renal diseases with American Society for Apheresis (ASFA) category I indication for TPE had an excellent outcome as compared to others. However, a high mortality was observed in view of delayed presentation with organ failure and lack of liver transplant facility.
Conclusion:
TPE is an effective treatment in hemolytic uremic syndrome (HUS) and anti-N-methyl-D-aspartate receptor encephalitis. TPE can be performed safely and effectively for renal and non-renal indications.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Pharmacokinetics in Pediatric Patients: Drug Distribution
Continuous Renal Replacement Therapy
Acute Kidney Injury V: Interprofessional Care
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

